BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 118613)

  • 1. Anion gap in multiple myeloma.
    Paladini G; Sala PG
    Acta Haematol; 1979; 62(3):148-52. PubMed ID: 118613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of chemotherapy on the anion gap in multiple myeloma.
    Paladini G; Sala PG
    Acta Haematol; 1981; 66(1):31-4. PubMed ID: 6794296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of anion-gap determination in multiple myeloma.
    De Troyer A; Stolarczyk A; De Beyl DZ; Stryckmans P
    N Engl J Med; 1977 Apr; 296(15):858-60. PubMed ID: 846496
    [No Abstract]   [Full Text] [Related]  

  • 4. Subclasses IgG1--IgG4 in 84 sera with IgG paraprotein.
    Tichý M; Hrncír Z; Mracek J
    Neoplasma; 1978; 25(1):107-10. PubMed ID: 634402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anion gap among patients of multiple myeloma and normal individuals.
    Mansoor S; Siddiqui I; Adil S; Nabi Kakepoto G; Fatmi Z; Ghani F
    Clin Biochem; 2007 Feb; 40(3-4):226-9. PubMed ID: 17156769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgA myeloma associated with decreased anion gap and renal failure.
    Fang JT; Kuo MC
    Ren Fail; 1997 May; 19(3):481-3. PubMed ID: 9154665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in serum anion gap and sodium level in monoclonal gammopathies.
    Nanji AA; Halstead AC
    Can Med Assoc J; 1982 Jul; 127(1):32-5. PubMed ID: 7083108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spurious hyperphosphataemia caused by an IgA paraprotein: a topic revisited.
    Sinclair D; Smith H; Woodhead P
    Ann Clin Biochem; 2004 Mar; 41(Pt 2):119-24. PubMed ID: 15025801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Isotypic characterization of IgA paraproteins: association with other clinical and analytic data].
    González González JB; García Delgado R; Cámara Sáez E; Ortiz Maslloréns F
    Rev Clin Esp; 1996 Aug; 196(8):529-35. PubMed ID: 8984539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anion gap as a screening procedure for occult myeloma in the elderly.
    Flanagan NG; Ridway JC; Irving AG
    J R Soc Med; 1988 Jan; 81(1):27-8. PubMed ID: 3343669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of paraproteins by immunoturbidimetry and electrophoresis followed by scanning densitometry.
    Sinclair D; Ballantyne F; Shanley S; Caine E; O'Reilly D; Shenkin A
    Ann Clin Biochem; 1990 Jul; 27 ( Pt 4)():335-7. PubMed ID: 2119564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Change of paraprotein from IgA to k chain in multiple myeloma.
    Omata F; Komatsuda M; Nagao T; Arimori S
    Am J Hematol; 1992 Jun; 40(2):159-60. PubMed ID: 1585921
    [No Abstract]   [Full Text] [Related]  

  • 13. Biosynthesis of immunoglobulin in human immunoproliferative diseases. II. Comparison of tumour cell mass in multiple myeloma measured by synthetic rate studies with that calculated from clinical staging systems.
    Cooper DA; Miller AC; Penny R
    Acta Haematol; 1982; 68(3):224-36. PubMed ID: 6814151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Myeloma with simultaneous occurrence of 2 paraproteins (IgA-K and IgG-L) in the serum].
    Hrncírová L; Sevelová D
    Vnitr Lek; 1970 Dec; 16(12):1200-5. PubMed ID: 5491519
    [No Abstract]   [Full Text] [Related]  

  • 15. Heavy/light chain specific immunoglobulin ratios provides no additional information than serum proteins electrophoresis and immunofixation for the diagnosis and the follow-up of intact immunoglobulin multiple myeloma patients.
    Beaumont-Epinette MP; Moreau C; Besnard S; Latute F; Collet N; Sebillot M; Grosbois B; Bendavid C; Guenet L; Decaux O
    Pathol Biol (Paris); 2015 Sep; 63(4-5):215-21. PubMed ID: 26319969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of multiple myeloma with IgA-K type pyroglobulinemia (author's transl)].
    Iida E; Ariga T; Watanabe Y; Tamura T; Ikeda Y
    Rinsho Byori; 1977 Feb; 25(2):152-6. PubMed ID: 558392
    [No Abstract]   [Full Text] [Related]  

  • 17. [Biclonal myeloma (IgG and IgA)].
    González Barón M; Martínez Fernández A; Durán A; Montero JM; Ordoñez A; Gasalla R
    Rev Clin Esp; 1973 Feb; 128(4):345-8. PubMed ID: 4700587
    [No Abstract]   [Full Text] [Related]  

  • 18. [Myelomatous paraproteinemia of the IgA or IgG type and blood lipids].
    Clerc M; Triquet A; Martine J
    Bull Soc Pathol Exot Filiales; 1974; 67(1):101-8. PubMed ID: 4219146
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute phase reactants and clinical stages in multiple myeloma.
    San Miguel J; Vicente V; Battle J; Hernandez F; Lopez Borrasca A
    Neoplasma; 1981; 28(3):333-8. PubMed ID: 7290260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual serum proteins and acute phase reactants in monoclonal immunoglobulinopathies (a study in patients with IgA myeloma and light chain myeloma).
    Wiedermann D; Widermann B; Cídl K; Scudla V
    Neoplasma; 1979; 26(3):315-24. PubMed ID: 119165
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.